trending Market Intelligence /marketintelligence/en/news-insights/trending/76MO6n60y6hxPn2TduE6aA2 content esgSubNav
In This List

PTC Therapeutics appoints 2 directors

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


PTC Therapeutics appoints 2 directors

PTC Therapeutics Inc. appointed Emma Reeve and Stephanie Okey to its board.

Reeve is the CFO of Constellation Pharmaceuticals Inc., while Okey was recently the senior vice president, head of North America at Genzyme's rare disease unit.

PTC Therapeutics is a biopharmaceutical company focused on developing medicines to treat rare disorders.